Skip to main content
AJNR: American Journal of Neuroradiology logoLink to AJNR: American Journal of Neuroradiology
. 2012 Nov;33(10):1939–1944. doi: 10.3174/ajnr.A3090

Hemodynamic Alterations in Vertebrobasilar Large Artery Disease Assessed by Arterial Spin-Labeling MR Imaging

BJ MacIntosh a,b,b,, L Marquardt a,d, UG Schulz a, P Jezzard a, PM Rothwell a
PMCID: PMC7964632  PMID: 22555580

Abstract

BACKGROUND AND PURPOSE:

VB artery stenosis is associated with a high risk of recurrent ischemic events, and knowledge about the hemodynamic relevance of VB stenosis is important for clinical decision making. In this study, multiple inflow pulsed ASL MR imaging was assessed for its ability to measure CBF and ATT in patients with VB disease.

MATERIALS AND METHODS:

ASL was performed on a 3T MR imaging scanner in 41 participants. Twenty-one patients had a history of ischemic events in the VB circulation (14 men, 7 women, age 66 ± 11 years). Clinical data and CE-MRA were used to classify VB disease severity. Twenty age-matched adults were controls. Group and within-VB analyses were performed. Mean CBF and ATT values in the ROIs were adjusted by excluding voxels that did not produce a reliable ASL estimate.

RESULTS:

CBF was reduced (P < .003) in patients compared with controls, which was significant after excluding voxels with a poor fit. Differences in ATT between patients and controls were not significant after voxel correction. There was a strong correlation between CBF and ATT among patients. Finally, ATT was significantly correlated with VB disease severity (P = .026).

CONCLUSIONS:

Multiple inflow ASL distinguished patients with VB disease from age matched-controls. VB disease rating was associated with prolonged ATT downstream. ASL may have diagnostic potential among patients in whom risk of intervention is high.


ASL MR imaging has gained clinical interest because of its ability to quantitatively image perfusion without the use of an injected contrast agent.1,2 In ASL, blood water is labeled magnetically in the proximal arteries to produce perfusion-weighted image contrast when the labeled blood reaches the imaging region.3 ASL data are often acquired by using a single inflow period to quantify perfusion, requiring assumed knowledge of the bolus transit time, defined here as the arterial transit time (ATT; in units of seconds). This approach is justified for healthy patients but might be problematic in cerebrovascular diseases where arterial flow is atypical or delayed, as in the case of ischemic scenarios.2,4 Recent work illustrates the value of multiple inflow ASL to extract both CBF and ATT information57

The current study focused on symptomatic VB circulation. In contrast to carotid circulation, the impact of stenotic disease on brain perfusion in VB circulation has not been reported in the literature thus far. ASL studies have shown that it is possible to assess perfusion specifically for the posterior circulation in the occipital region.8,9 Patients with VB stenotic disease have a high risk of recurrent ischemic events.1012 In addition, intervention in VB stenotic disease is associated with a high procedural risk and its benefit is currently the object of clinical trials (eg, Vertebral Artery Ischemia Stent Placement Trial, Vertebral Artery Stent Placement Trial). Information about the hemodynamic relevance of VB stenotic disease may help target candidates suitable for revascularization by identifying patients with poor cerebral perfusion. In the current study, we hypothesize it is possible to use multiple inflow ASL to distinguish patients with VB circulation ischemic events from age-matched controls. From the multiple inflow ASL, we are able to produce images of CBF and ATT. In addition, we estimate the proportion of ASL voxels that produced significant estimates for the hemodynamic parameters. Finally, we hypothesize that ASL data will be correlated with VB disease severity.

Materials and Methods

Patients and Controls

In this cross-sectional observational study, we enrolled patients who attended the TIA clinic of the John Radcliffe Hospital, Oxford, United Kingdom, with a previous diagnosis of TIA or minor stroke in the VB circulation. Standardized clinical data, including previous medical history and vascular risk factors, were recorded. Patients had brain MR imaging (standard stroke protocol, including T2, T2*, FLAIR, DWI) and vascular imaging of the cervical and proximal intracranial vessels with CE-MRA. All patients had their event at least 2 months before undergoing ASL perfusion imaging.

Three neurologists (L.M., U.S., P.M.R.) independently reviewed the clinical and radiologic data and categorized the patients into 3 groups according to the presence and degree of severity of any VB stenotic disease. In cases of disagreement, a consensus was sought. Group 1 included patients with a VB circulation ischemic event but no evidence of VB stenosis (no VB) on CE-MRA. Group 2 patients had moderate VB stenosis (moderate VB) on CE-MRA. Group 2 included patients with unilateral vertebral artery stenosis and/or good collateral flow from the anterior circulation. Finally, group 3 consisted of patients with severe VB disease (severe VB), described by bilateral vertebral artery stenosis or occlusion and/or significant basilar artery stenosis, with little to no evidence of cross-flow from the anterior to posterior circulation via the circle of Willis. The control cohort consisted of 20 age-matched and sex-matched participants with no known history of cerebrovascular disease or stroke. The local ethics committee approved the study.

MR Imaging

ASL MR imaging was performed on a 3T MR imaging system (Tim Trio; Siemens, Erlangen, Germany) using a 12-channel head receive coil. Pulse sequences with imaging parameters included 1) pulsed ASL perfusion imaging (TR/TE = 3216/40 ms in 8 of 21 patients and TR/TE = 3166/23 ms for remaining patients/participants; 200 × 200 × 130 mm field of view; 26 sections; 3.1 × 3.1 × 5 mm3 voxels; 5/8 partial k-space; 10 inversion times; inflow time, 10 control-tag difference pairs for a 10.5-minute scan duration), 2) diffusion-weighted imaging (TR/TE = 4400/93 ms; 27 sections; 1.6 × 1.6 × 3 mm3 voxels; b-value = 0,1000s/mm2), 3) FLAIR (TR/TI/TE = 13,970/2500/94 ms; 27 sections; 1 × 1 × 2.5 mm3 voxels), and 4) T1-weighted anatomic images (TR/TE = 1250/4.6 ms; 44 slabs; 3D turbo fast low-angle shot; 2x parallel imaging; 1 × 1 × 2.5 mm3 voxels). Flow-sensitive alternating inversion recovery-pulsed ASL was used to create section-selective (control) and nonselective (tag) images and to consequently tag a large volume of arterial blood water. The tagging geometry was designed so that the section-selective tagging volume was 10% larger than the field of view along z (FOVz; ie, 121-mm slab thickness versus 110 mm for FOVz). This leads to a 5.5-mm gap between the tag region and the imaging slab. In addition, 2 background suppression inversion pulses were used to null gray and white matter signal. The method of Q2TIPS was used to constrain the maximum duration of the ASL label. Although a Q2TIPS TI1 value of 1.6 s was used for all experiments, in practice, we find that for this duration of inflow time 1, the extent of the radio-frequency transmit coil profile acts as an effective limit to the bolus duration. The remaining uncertainty in inflow time 1 was therefore included in the fitting of the data to the kinetic model.13 ASL imaging was performed using 3D GRASE.13,14 Data were collected over a range of inflow times to produce an ASL time series. The first and last inflow times were 400 ms and 2200 ms, respectively, for the patients, with 200-ms increments, and 400 ms and 2100 ms, respectively, for the controls, with 170-ms increments. ASL parametric estimates were 1) CBF (mL/100 g/min), and 2) ATT (s). A reference ASL image (18 seconds) was acquired without any arterial labeling preparation to calculate the initial magnetization of arterial blood water.

Data Processing

ASL images were processed by using tools supplied by the FSL. Spatial smoothing involved a full width at half maximum smoothing filter of 6 mm. Perfusion-weighted difference images were calculated by using sinc-interpolated subtraction for control and tag images at each inflow time.15 Difference images were averaged at each inflow time. A single-compartment 2-parameter model16 was implemented in Matlab (MathWorks, Natick, Massachusetts) to calculate CBF and ATT voxelwise. Model parameters included bolus duration = 900 ms, which was verified empirically, as in,13 T1,blood = 1500 ms, T1,tissue = 1300 ms. Goodness-of-fit was assessed on a voxel-by-voxel basis using the confidence intervals that were generated from the model fitting for CBF and ATT, as defined by the following criteria: 1) if the CBF estimate minus the 95% lower-bound confidence interval was greater than zero, the fit to the CBF parameter was considered significant (CBF-sig), and 2) if the ATT estimate plus the 95% upper-bound confidence interval was less than the longest inflow value (TImax), the fit to the ATT fit was considered significant (ATT-sig). TImax was 2200 ms for patients and 2100 ms for controls. The percentage of significant voxels within the ROI was determined for the CBF and ATT data, denoted as percent CBF-sig voxels and percent ATT-sig voxels, respectively.

CBF images were converted to absolute units (ie, mL/100 g/min) by conducting the following steps: 1) estimating the initial arterial blood magnetization (M0,blood) from a ROI in the ventricles and using a proton attenuation ratio for tissue and CSF, 2) correcting for the receiver coil sensitivity across the brain, 3) correcting for the T2 difference between CSF and tissue by incorporating the following ratio expression: exp(−TE/T2,blood)/exp(−TE/T2,CSF),17 and 4) assuming a labeling efficiency (ε = 0.81) associated with 2 background suppression pulses in pulsed ASL.18 T1-weighted anatomic images were collected in the same orientation as the ASL data to facilitate registration to MNI standard space. ROIs in occipital and parietal gray matter shown in Fig 1 were selected from the MNI structural atlas that is available in FSLview. The ROIs were warped to the individual patient coordinate space and voxels were included in the ROI if they had a significant fit for CBF or ATT.

Fig 1.

Fig 1.

Axial CBF (left; mL/100 g/min) and ATT (middle left; seconds) images. A, A representative control shows anterior and posterior regions had a longer ATT compared with middle cerebral territory, while CBF was relatively uniform across the cortex. B, Patient 16 (P16; no VB) had normal CBF and ATT patterns. C, P2 (mod VB) has reduced CBF and prolonged ATT in the posterior portion of the cortex. A patient with severe VB disease (sev VB, P1) also showed reduced CBF and prolonged ATT. Voxels with zero intensity in C-D occurred due to poor fitting. The 2 right columns show the standard space ROIs that were altered to include only voxels that showed a significant fit for CBF or ATT.

Statistics

SPSS was used to perform statistical analyses (SPSS 19, SPSS, Chicago, Illinois). For the group comparisons, an unpaired t test was performed on CBF, ATT, % CBF-sig voxels, % ATT-sig voxels, CBF-sig, and ATT-sig. An empirical relationship between CBF and ATT was sought for controls and patients by regression analysis. Curve fitting was performed in SPSS using both a linear model and an exponential model. Finally, a within-VB patients 1-way analysis of variance was performed on these data by separating patients based of the 3 VB ratings.

Results

We recruited 21 patients (14 men, mean age 66 years, SD 11 years) and 20 healthy controls to the study. There was no significant difference in age or sex between patients and controls (P < .87, P < .79, respectively). DWI scans showed no evidence for acute ischemia at the time of the MR imaging. Table 1 shows the clinical details of the patients, the CE-MRA vascular imaging findings, and the category of severity of VB-disease, as determined by the neurologic review.

Table 1:

Patient demographics, including history of stroke or TIA, infarcts, and arterial disease

Patient Age (years) Sex Stroke/TIA Brain Infarct Carotid Stenosis VB Stenosis VB Rating
1 62 M Multiple TIAs R thalamus and pons No Severe R VA, occlusion L VA Severe
2 65 M Stroke R cerebellar, bilat occipital No High-grade R VA Moderate
3 71 F Stroke, multiple TIAs No No High-grade R VA, low-grade L VA Severe
4 49 M Stroke, then TIA R cerebellar No Occlusion R VA, low-grade L VA Moderate
5 59 F Stroke, then TIA No No Bilateral VA, moderate BA Moderate
6 54 M Stroke Bilat cerebellar, R occipital No L VA occluded, high-grade R VA Severe
7 50 M Multiple TIAs No No Moderate BA Moderate
8 87 M Stroke No No No None
9 79 M TIA No L 20%, R 30% No None
10 52 M TIA No No Low-grade L VA None
11 76 F Stroke No No No None
12 52 F Stroke Occipital No No None
13 64 F TIA No No No None
14 73 M TIA No R ICA No None
15 75 F TIA No L 20%, R 15% No None
16 73 M TIA No No No None
17 50 F Stroke L occipital No R VA stenosis Moderate
18 75 M Multiple TIAs R cerebellar No Occlusion R VA Moderate
19 78 M TIA, then stroke No No Severe BA Severe
20 70 M Multiple TIAs No No Medium-grade bilateral VA Moderate
21 62 M TIA No L 20%, R 20% No None

Note:—Expected degree of hypoperfusion is based on blinded and unanimous agreement from 3 neurologists. Bilat indicates bilateral; L, left; R, right; VA, vertebral artery.

Figure 1 shows CBF and ATT images for representative participants. The figure shows a 65-year-old control participant (Fig 1A), followed by patients sorted by their VB disease severity. Fig 1B shows a 73-year-old man with no VB disease (P16). CBF and ATT images in Fig 1A, -B appear normal. Fig 1C shows a 65-year-old male patient with moderate VB disease (P2). Fig 1D shows P1, with a left vertebral occlusion and severe right vertebral stenosis. Fig 1C, -D demonstrate regions with reduced CBF, prolonged ATT, or both.

Comparison between Patients and Controls

The percentage of voxels that showed a significant fit was different between groups for CBF in the parietal region of interest (92 ± 9.5% for controls versus 81 ± 19.3% for patients, P = .021) and occipital region of interest (97 ± 4.3% for controls versus 85 ± 19.9% for patients, P = .024). Similarly, for ATT, the percentage of significant voxel fits was higher in controls in the parietal region of interest (98 ± 4.8% for controls versus 91 ± 12.9% for patients, P = .033) and occipital region of interest (99 ± 1.8% for controls versus 92 ± 13.2% for patients, P = .024). Table 2 shows CBF was reduced in patients compared with controls in the occipital region of interest (P = .10) and parietal ROIs (P = .003). After excluding voxels that showed a poor CBF fit, the occipital region of interest remained significant (P = .003), while the parietal ROI was not (P = .161). Neither region of interest showed a significant ATT difference between groups (P > .09).

Table 2:

CBF and ATT for patients with VB disease and controls separated by group and ROI

Control (n = 20)
Patient (n = 21)
Between-GroupsP Value Within-VBP Value
Mean SD Mean SD
CBF (mL/100 g/min)
    PAR 29.7 7.5 24.9 10.1 0.096 0.459
    OCC 31.8 10.5 21.8 9.9 0.003a 0.371
CBF-sig (mL/100 g/min)
    PAR 31.3 6.5 27.9 8.7 0.161 0.359
    OCC 32.4 10.1 22.6 9.6 0.003a 0.307
ATT (s)
    PAR 0.75 0.10 0.84 0.20 0.094 0.763
    OCC 0.82 0.11 0.87 0.34 0.599 0.026b
ATT-sig (s)
    PAR 0.73 0.08 0.76 0.13 0.438 0.059
    OCC 0.82 0.10 0.81 0.26 0.918 0.010b

Note:—The percentage of significant voxels for CBF and ATT are shown (ie, % CBF-sig voxels and % ATT-sig voxels). ROI-adjusted CBF-sig and ATT-sig are shown, achieved by excluding voxels with a poor fit. For group comparison, a indicates a significant difference (P < .05). For within-VB analysis, b indicates a significant within-VB difference (P < .05). OCC indicates occipital cortex; PAR, parietal cortex.

Fig 2 shows CBF versus ATT for controls (Fig 2A) and patients (Fig 2B). The CBF versus ATT curve fitting was not significant for controls (P = .06). For patients, however, both linear and exponential curves were significant (P < .001), with the exponential curves explaining a greater proportion of the variance (r2 = 0.25 and r2 = 0.31, respectively).

Fig 2.

Fig 2.

Empirical characterization of CBF and ATT for controls (top) and patients with VB disease (bottom). Lower CBF values were associated with longer ATT. The ATT range was greater among patients. Linear and exponential curves are shown. Curve fitting was significant for patients (P < .001) but not controls.

Within-VB Patient Analysis

Table 2 shows the results of the 1-way ANOVA and revealed a significant relationship between occipital ATT and VB disease rating (P = .026), which was significant when considering only ATT-sig voxels (P = .010). To address the small sample size for the severe and moderate VB subgroups, a test of homogeneity of the variance was performed and found not to be significantly different between subgroups (P > .235).

Discussion

This study demonstrates that multiple inflow ASL can be used to characterize hemodynamics among patients with symptomatic VB large artery stenotic disease. These results extend the work of previous clinical ASL studies 2,57,1921 by showing that CBF is reduced in the VB circulation in patients compared with controls. Significance of ASL fitting was assessed voxelwise using the 95% confidence intervals produced from the ASL model fitting. The percentage of the CBF-sig and ATT-sig voxels was lower among patients compared with controls, which suggests that a wider inflow time schedule among patients may have been useful. Further, it was possible to evaluate the impact of including voxels that showed a poor fit, which is a new approach in ASL. Excluding voxels within the region of interest that showed a poor fit did not substantially alter the results. We observed an empirical relationship between CBF and ATT that was significant among VB patients. Finally, occipital ATT was strongly related to VB disease severity rating.

Our focus was on patients with VB large artery stenotic disease, which is an area of research that is underreported in the perfusion literature compared with carotid disease.8,19,22 In addition, to our knowledge, this is the first study that has attempted to assess fitting results from the ASL model in a clinical population. Analyses could be extended to incorporate the number of ASL difference pairs that are required to produce reliable estimates23 or by using a bootstrap approach on the residuals to assess the reliability of the ASL estimates.24

Within-VB analysis showed ATT was significantly correlated with VB disease severity, which suggests ATT may be a good marker of hemodynamic alteration downstream of atherosclerotic stenoses. Future work could compare ATT with more established techniques like digital subtraction angiography. ATT was not significantly different between patients and controls because the patient group showed a large ATT variance. Although ATT is quantitative, it is dependent on the imaging volume and labeling schemes, so it can be difficult to compare between studies. Our ATT values among controls were consistent with our previous work that used pulsed ASL 3D GRASE. Furthermore, the maximum measurable ATT is determined by the longest inflow value. On the basis of the percent ATT-sig voxels, it was possible to estimate ATT voxelwise in greater than 80% of the voxels. A post hoc analysis revealed that the percentage of voxels that met the lower-bound ATT threshold (ie, greater than zero) was correlated with the percentage of voxels from the upper-bound ATT threshold. Ultimately, this illustrates that participants with a poor upper-bound ATT fit also showed a poor lower-bound fit, suggesting our metric for ATT significant voxel fitting was reasonable.

Recent work highlights the value of ATT,21,25 while others have used the arterial transit artifact from single-inflow pseudocontinuous ASL to quantify collateral flow.4 Another ATT acquisition approach is to perform multiple inflow ASL with a lower spatial resolution acquisition that requires fewer averages to estimate ATT.26 We characterized the relationship between CBF and ATT and found a significant trend among patients. The data showed that ATT increased faster than CBF decreased among patients, as suggested by an exponential curve. Future work is warranted to establish how ATT is influenced by intra- and extracranial vascular disease.

The current study is not without limitations. First, analysis was restricted to the cortical regions, despite knowledge that the VB circulation includes the brain stem and cerebellum,27 as the ASL acquisition did not adequately cover lower brain regions. Second, our ASL implementation did not incorporate flow-crushing gradients and we did not model large-artery contributions to the ASL signal.28 Recent work by our group has shown, however, that large vessel signals using pulsed ASL 3D GRASE tend to occur mainly near the middle cerebral arteries.29 Consequently, we do not expect this to be a major issue in the current study. Third, absolute CBF values were comparable with other perfusion studies involving older or patient populations,21,3032 but were still generally lower than might be expected. We attribute this to through-plane partial volume blurring associated with the current ASL implementation, which accentuates partial volume effects with white-matter voxels. The quantification method was consistent for all participants, thus within- and between-groups results are valid.

Conclusions

We have demonstrated that cortical perfusion and hemodynamics are altered in patients with underlying VB large artery disease. The multiple inflow ASL allowed for estimation of CBF and ATT, as well as the proportion of significant voxels within the ROIs. ASL perfusion imaging is a noninvasive method that can be used to determine the hemodynamic relevance and perfusion patterns in patients with cerebrovascular stenotic disease, which ultimately may be useful when deciding upon treatment options.

Acknowledgments

We thank Dr. Nicola Filippini for contributing to data collection.

ABBREVIATIONS:

ASL

arterial spin-labeling

ATT

arterial transit time

CE-MRA

contrast-enhanced MRA

GRASE

gradient and spin echo

MNI

Montreal Neurological Institute

Q2TIPS

quantitative imaging of perfusion with a single subtraction with thin-section TI1 periodic saturation

sig

significant

VB

vertebrobasilar

Footnotes

This work was funded by the UK Medical Research Council, Dunhill Medical Trust (P.J.); the Stroke Association, National Institute for Health Research, NIHR Clinician Scientist Fellowship (U.G.S.); and the NIHR Oxford Partnership Comprehensive Biomedical Research Centre and Heart and Stroke Foundation of Canada (B.J.M.).

Disclosures: Bradley MacIntosh—RELATED: Grant: Heart and Stroke Foundation of Canada, Comments: Postdoctoral fellowship award; UNRELATED: Grants/Grants Pending: NIHR Oxford Partnership Comprehensive Biomedical Research Centre. Ursula Schulz—RELATED: Grant: National Institute for Health Research (NIHR), Comments: Dr. U.G. Schulz is funded by an NIHR-Clinician Scientist Fellowship. Peter Jezzard—RELATED: Grant: MRC,* Dunhill Medical Trust,* Stroke Association,* NIHR,* Stroke Foundation of Canada,* Comments: All gave grant funding; Support for Travel to Meetings for the Study or Other Purposes: MRC,* Dunhill Medical Trust,* Comments: Travel funds for students and postdocs. (* Money paid to institution)

References

  • 1. Alsop DC, Detre JA.. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236–49 [DOI] [PubMed] [Google Scholar]
  • 2. Chalela JA, Alsop DC, Gonzalez-Atavales JB, et al. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000;31:680–87 [DOI] [PubMed] [Google Scholar]
  • 3. Williams DS, Detre JA, Leigh JS, et al. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 1992;89:212–16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Zaharchuk G, Do HM, Marks MP, et al. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with Moyamoya disease. Stroke 2011;42:2485–91 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Bokkers RP, van Laar PJ, van de Ven KC, et al. Arterial spin-labeling MR imaging measurements of timing parameters in patients with a carotid artery occlusion. AJNR Am J Neuroradiol 2008;29:1698–703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Bokkers RP, Bremmer JP, van Berckel BN, et al. Arterial spin labeling perfusion MRI at multiple delay times: a correlative study with H215O positron emission tomography in patients with symptomatic carotid artery occlusion. J Cereb Blood Flow Metab 2010;30:222–29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. MacIntosh BJ, Lindsay AC, Kylintireas I, et al. Multiple inflow pulsed arterial spin-labeling reveals delays in the arterial arrival time in minor stroke and transient ischemic attack. AJNR Am J Neuroradiol 2010;31:1892–94 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Kansagra AP, Wong EC.. Mapping of vertebral artery perfusion territories using arterial spin labeling MRI. J Magn Reson Imaging 2008;28:762–66 [DOI] [PubMed] [Google Scholar]
  • 9. Hendrikse J, van der Grond J, Lu H, et al. Flow territory mapping of the cerebral arteries with regional perfusion MRI. Stroke 2004;35:882–87 [DOI] [PubMed] [Google Scholar]
  • 10. Chimowitz MI.. Prognosis of patients with symptomatic vertebral or basilar artery stenosis The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) study group. Stroke 1998;29:1389–92 [DOI] [PubMed] [Google Scholar]
  • 11. Flossmann E, Rothwell PM.. Prognosis of vertebrobasilar transient ischaemic attack and minor stroke. Brain 2003;126:1940–54 [DOI] [PubMed] [Google Scholar]
  • 12. Marquardt L, Kuker W, Chandratheva A, et al. Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain 2009;132:982–88 [DOI] [PubMed] [Google Scholar]
  • 13. MacIntosh BJ, Filippini N, Chappell MA, et al. Assessment of arterial arrival times derived from multiple inversion time pulsed arterial spin labeling MRI. Magn Reson Med 2010;63:641–47 [DOI] [PubMed] [Google Scholar]
  • 14. Günther M, Oshio K, Feinberg DA.. Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements. Magn Reson Med 2005;54:491–98 [DOI] [PubMed] [Google Scholar]
  • 15. Mumford JA, Hernandez-Garcia L, Lee GR, et al. Estimation efficiency and statistical power in arterial spin labeling fMRI. Neuroimage 2006;33:103–14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Buxton RB, Frank LR, Wong EC, et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40:383–96 [DOI] [PubMed] [Google Scholar]
  • 17. MacIntosh BJ, Pattinson KT, Gallichan D, et al. Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling. J Cereb Blood Flow Metab 2008;28:1514–22 [DOI] [PubMed] [Google Scholar]
  • 18. Ye FQ, Frank JA, Weinberger DR, et al. Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST). Magn Reson Med 2000;44:92–100 [DOI] [PubMed] [Google Scholar]
  • 19. Hendrikse J, van Osch MJ, Rutgers DR, et al. Internal carotid artery occlusion assessed at pulsed arterial spin-labeling perfusion MR imaging at multiple delay times. Radiology 2004;233:899–904 [DOI] [PubMed] [Google Scholar]
  • 20. Kim HS, Kim SY, Kim JM.. Underestimation of cerebral perfusion on flow-sensitive alternating inversion recovery image: semiquantitative evaluation with time-to-peak values. AJNR Am J Neuroradiol 2007;28:2008–13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Yoshiura T, Hiwatashi A, Yamashita K, et al. Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease. AJNR Am J Neuroradiol 2009;30:1388–93 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Moftakhar R, Turk AS, Niemann DB, et al. Effects of carotid or vertebrobasilar stent placement on cerebral perfusion and cognition. AJNR Am J Neuroradiol 2005;26:1772–80 [PMC free article] [PubMed] [Google Scholar]
  • 23. Fernández-Seara MA, Edlow BL, Hoang A, et al. Minimizing acquisition time of arterial spin labeling at 3T. Magn Reson Med 2008;59:1467–71 [DOI] [PubMed] [Google Scholar]
  • 24. Jones DK, Pierpaoli C.. Confidence mapping in diffusion tensor magnetic resonance imaging tractography using a bootstrap approach. Magn Reson Med 2005;53:1143–49 [DOI] [PubMed] [Google Scholar]
  • 25. Bokkers RP, van der Worp HB, Mali WP, et al. Noninvasive MR imaging of cerebral perfusion in patients with a carotid artery stenosis. Neurology 2009;73:869–75 [DOI] [PubMed] [Google Scholar]
  • 26. Wu WC, St Lawrence KS, Licht DJ, et al. Quantification issues in arterial spin labeling perfusion magnetic resonance imaging. Top Magn Reson Imaging 2010;21:65–73 [DOI] [PubMed] [Google Scholar]
  • 27. Tatu L, Moulin T, Bogousslavsky J, et al. Arterial territories of the human brain: cerebral hemispheres. Neurology 1998;50:1699–708 [DOI] [PubMed] [Google Scholar]
  • 28. Ye FQ, Mattay VS, Jezzard P, et al. Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med 1997;37:226–35 [DOI] [PubMed] [Google Scholar]
  • 29. Chappell MA, MacIntosh BJ, Donahue MJ, et al. Separation of macrovascular signal in multi-inversion time arterial spin labelling MRI. Magn Reson Med 2010;63:1357–65 [DOI] [PubMed] [Google Scholar]
  • 30. Hosoda K, Kawaguchi T, Shibata Y, et al. Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke 2001;32:1567–73 [DOI] [PubMed] [Google Scholar]
  • 31. Ogasawara K, Yukawa H, Kobayashi M, et al. Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning. J Neurosurg 2003;99:504–10 [DOI] [PubMed] [Google Scholar]
  • 32. Zaharchuk G, Straka M, Marks MP, et al. Combined arterial spin label and dynamic susceptibility contrast measurement of cerebral blood flow. Magn Reson Med 2010;63:1548–56 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from AJNR: American Journal of Neuroradiology are provided here courtesy of American Society of Neuroradiology

RESOURCES